Search Results - "Alsdorf, W."

Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis by Seidel, C., Schaefers, C., Connolly, E.A., Weickhardt, A., Grimison, P., Wong, V., De Giorgi, U., Hentrich, M., Zschäbitz, S., Ochsenreither, S., Vincenzi, B., Oing, C., Bokemeyer, C., Engel, N., Alsdorf, W., Tran, B.

“…In relapsed or refractory (RR) metastatic germ cell cancer (GCC), high-dose (HD) chemotherapy (CTX) plus autologous stem cell transplantation is considered the…”
Get full text

1037P Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19) in patients with solid tumors by Mach, N., Belli, C., Fernandez, E., Alsdorf, W., Colombo, I., Dakhel, S., Hemmerle, T., Puca, E., Libbra, C., Mulatto, S., Mock, J.C., Lorizzo, K., Neri, D., Covelli, A., Lauer, U., Hassel, J.C., Stathis, A., Fiedler, W.M., Curigliano, G.

Get full text

LBA35 BNT211-01: Interim results from a repeat dose escalation study of CLDN6 CAR-T cells manufactured with an automated process ± a CLDN6-encoding CAR-T cell-amplifying RNA Vaccine (CARVac) by Mackensen, A., Haanen, J.B.A.G., Alsdorf, W., Koenecke, C., Wagner-Drouet, E., Borchmann, P., Heudobler, D., Busse, A., Klobuch, S., Kutsch, N., Müller, F., Bokemeyer, C., Desuki, A., Lueke, F., Ho, T., Vemuri, K., Preussner, L., Rengstl, B., Türeci, Ö., Sahin, U.

Get full text

732P Efficacy and safety of high-dose chemotherapy as second or subsequent salvage therapy in relapsed or refractory germ cell cancer patients: A multicentric analysis by Seidel, C., De Giorgi, U.F.F., Engel, N., Hentrich, M., Zschäbitz, S., Conolly, E., Weickhardt, A.J., Grimison, P., Wong, V., Oing, C., Alsdorf, W., Schaefers, C., Bokemeyer, C., Tran, B.

Get full text

In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells by El-Heliebi, Amin, Hille, Claudia, Laxman, Navya, Svedlund, Jessica, Haudum, Christoph, Ercan, Erkan, Kroneis, Thomas, Chen, Shukun, Smolle, Maria, Rossmann, Christopher, Krzywkowski, Tomasz, Ahlford, Annika, Darai, Evangelia, von Amsberg, Gunhild, Alsdorf, Winfried, König, Frank, Löhr, Matthias, de Kruijff, Inge, Riethdorf, Sabine, Gorges, Tobias M, Pantel, Klaus, Bauernhofer, Thomas, Nilsson, Mats, Sedlmayr, Peter

“…Liquid biopsies can be used in castration-resistant prostate cancer (CRPC) to detect androgen receptor splice variant 7 (AR-V7), a splicing product of the…”
Get full text

LBA1 BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+ advanced solid tumors by Haanen, J., Mackensen, A., Koenecke, C., Alsdorf, W., Desuki, A., Wagner-Drouet, E., Heudobler, D., Borchmann, P., Wiegert, E., Schulz, C., Rengstl, B., Preußner, L., Türeci, Ö., Sahin, U.

Get full text

LBA38 BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours by Mackensen, A., Haanen, J.B.A.G., Koenecke, C., Alsdorf, W., Wagner-Drouet, E., Heudobler, D., Borchmann, P., Bokemeyer, C., Klobuch, S., Smit, E., Müller, F., Desuki, A., Lüke, F., Wiegert, E., Flemmig, C., Schulz-Eying, C., Rengstl, B., Preussner, L., Türeci, Ö., Sahin, U.

Get full text

Pretrial Risk Assessment: Improving Public Safety and Fairness in Pretrial Decision Making by Milgram, Anne, Holsinger, Alexander M., Vannostrand, Marie, Alsdorf, Matthew W.

“…On any given day, approximately half a million people in the United States are in jail awaiting the resolution of their cases. In fact, these pretrial…”
Get full text

Pretrial Risk Assessment by Milgram, Anne, Holsinger, Alexander M., Vannostrand, Marie, Alsdorf, Matthew W.

Get full text

An accurate colorimetric method for the determination of methanol on blood, tissues, and the expired air by HINE, C H, SHEA, Jr, T E, ALSDORF, W R

Get more information